SPRY icon

ARS Pharmaceuticals

113 hedge funds and large institutions have $612M invested in ARS Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 36 increasing their positions, 27 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding in top 10

Funds holding in top 10:

33% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 27

13% more funds holding

Funds holding: 100113 (+13)

6.2% less ownership

Funds ownership: 68.26%62.06% (-6.2%)

Holders
113
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$6.42M
Puts
$1.02M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$113M
2
$111M
3
$94.4M
4
$41M
5
$30.2M
6
$29.5M
7
$27.2M
8
$22.7M
9
$19.5M
10
$16.4M
11
$11.1M
12
$8.96M
13
$8.86M
14
$6.53M
15
$5.71M
16
$5.48M
17
$4.73M
18
$4.2M
19
$4.11M
20
$3.53M
21
$2.84M
22
$2.81M
23
$2.79M
24
$2.68M
25
$2.44M